1. Home
  2. ARVN vs YY Comparison

ARVN vs YY Comparison

Compare ARVN & YY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • YY
  • Stock Information
  • Founded
  • ARVN 2015
  • YY 2005
  • Country
  • ARVN United States
  • YY Singapore
  • Employees
  • ARVN N/A
  • YY N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • YY EDP Services
  • Sector
  • ARVN Health Care
  • YY Technology
  • Exchange
  • ARVN Nasdaq
  • YY Nasdaq
  • Market Cap
  • ARVN 1.8B
  • YY 1.9B
  • IPO Year
  • ARVN 2018
  • YY 2012
  • Fundamental
  • Price
  • ARVN $18.48
  • YY $40.78
  • Analyst Decision
  • ARVN Strong Buy
  • YY Hold
  • Analyst Count
  • ARVN 13
  • YY 3
  • Target Price
  • ARVN $63.00
  • YY $35.00
  • AVG Volume (30 Days)
  • ARVN 967.8K
  • YY 721.6K
  • Earning Date
  • ARVN 10-30-2024
  • YY 11-26-2024
  • Dividend Yield
  • ARVN N/A
  • YY 1.96%
  • EPS Growth
  • ARVN N/A
  • YY N/A
  • EPS
  • ARVN N/A
  • YY 3.11
  • Revenue
  • ARVN $161,100,000.00
  • YY $2,258,181,000.00
  • Revenue This Year
  • ARVN $237.44
  • YY $0.62
  • Revenue Next Year
  • ARVN N/A
  • YY $1.84
  • P/E Ratio
  • ARVN N/A
  • YY $13.10
  • Revenue Growth
  • ARVN 1.07
  • YY N/A
  • 52 Week Low
  • ARVN $17.37
  • YY $27.88
  • 52 Week High
  • ARVN $53.08
  • YY $42.76
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 32.78
  • YY 59.63
  • Support Level
  • ARVN $17.37
  • YY $35.01
  • Resistance Level
  • ARVN $19.21
  • YY $40.37
  • Average True Range (ATR)
  • ARVN 1.64
  • YY 1.87
  • MACD
  • ARVN -0.59
  • YY -0.31
  • Stochastic Oscillator
  • ARVN 11.80
  • YY 77.04

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About YY JOYY Inc.

JOYY Inc is a global technology company offering comprehensive innovation capabilities. The company enables users to interact with others in real time. The group is actively exploring and expanding its global commerce Software-as-a-Service and solutions business. JOYY emphasizes technological innovation and is recognized in the industry for its significant number of patent applications and licenses.

Share on Social Networks: